説明
The ex vivo addition of BD GolgiPlug™, a protein transport inhibitor containing brefeldin A, to in vitro- or in vivo-stimulated lymphoid cells blocks their intracellular protein transport processes. This results in the accumulation of cytokines and/or proteins in the Golgi complex. This increased accumulation of cytokines in the cell enhances the detectability of cytokine-producing cells with immunofluorescent staining and flow cytometric analysis.
調製と保管タイトルテキスト
推奨アッセイ手順
Stimulation of cells: Various in vitro methods have been reported for stimulated cells to produce cytokines. Polyclonal activators have been particularly useful for inducing cytokine-producing cells. These activators include the following: concanavalin A, lipopolysaccharide, phorbol esters plus calcium ionophore or ionophore or ionomycin, phytohaemaglutinin, staphylococcus, enterotoxin B, and monoclonal antibodies directed against subunits of the TCR/CD3 complex (with or without antibodies directed against costimulatory receptors, such as CD28).
Procedure for using BD GolgiPlug™: Add 1 µl of BD GolgiPlug™ for every 1 ml of cell culture (e.g., ~10^6 cells/mL) and mix thoroughly. Treatment of stimulated cells for 4 to 6 hours with BD GolgiPlug™ significantly increases the ability to detect cytokine-producing cells by immunofluorescent staining. It is recommended that BD GolgiPlug™ not be kept in cell culture for longer than 12 hours.
As an alternative to BD GolgiPlug™, investigators may wish to consider using BD GolgiStop™, a protein transport inhibitor containing monensin (Cat. No. 554724). BD GolgiPlug™ and BD GolgiStop™ have been found to have differential effects on intracellular cytokine staining that is time, activator and cytokine dependent. These factors need to be considered when carrying out intracellular cytokine staining.
製品通知
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
コンパニオン製品
Development References (1)
-
Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods. 1995; 188(1):117-128. (Methodology). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
